| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 58,600 | $1 | $234.4K |
| J0897 | Injection, denosumab, 1 mg | 12,060 | $20 | $229.1K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 27,300 | $10 | $218.4K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 5,300 | $30 | $180.2K |
| J3262 | Injection, tocilizumab, 1 mg | 18,920 | $10 | $94.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 480 | $90 | $43.2K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,470 | $30 | $38.2K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 320 | $60 | $17.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 110 | $100 | $11.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 110 | $60 | $6.8K |